Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brigitta Derendinger

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
International Journal of Pharmaceutics|February 26, 2008
Comparative diffusion of drugs through bronchial tissueJohann M van Zyl, Brigitta Derendinger, Heiner I Seifart, et al.
Scientific Reports|February 16, 2020
Extract from used Xpert MTB/RIF Ultra cartridges is useful for accurate second-line drug-resistant tuberculosis diagnosis with minimal rpoB-amplicon cross-contamination riskRouxjeane Venter, Stephanie Minnies, Brigitta Derendinger, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 2, 2021
Diagnostic accuracy of the FluoroType MTB and MTBDR VER 2.0 assays for the centralized high-throughput detection of Mycobacterium tuberculosis complex DNA and isoniazid and rifampicin resistanceAnzaan Dippenaar, Brigitta Derendinger, Tania Dolby, et al.
The Journal of Molecular Diagnostics : JMD|February 2, 2022
Frequent Suboptimal Thermocycler Ramp Rate Usage Negatively Impacts GenoType MTBDRsl VER 2.0 Performance for Second-Line Drug-Resistant Tuberculosis DiagnosisBrigitta Derendinger, Margaretha de Vos, Samantha Pillay, et al.
Journal of Clinical Microbiology|July 7, 2018
Diagnostic Accuracy and Utility of FluoroType MTBDR, a New Molecular Assay for Multidrug-Resistant TuberculosisMargaretha de Vos, Brigitta Derendinger, Tania Dolby, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 5, 2022
Non-actionable Results, Accuracy, and Effect of First- and Second-line Line Probe Assays for Diagnosing Drug-Resistant Tuberculosis, Including on Smear-Negative Specimens, in a High-Volume LaboratorySamantha Pillay, Margaretha de Vos, Brigitta Derendinger, et al.
Journal of Clinical Microbiology|July 1, 2025
Waste to worth: diagnostic accuracy of Xpert MTB/XDR on contaminated liquid cultures to salvage the detection of drug-resistant tuberculosisYonas Ghebrekristos, Erick Auma, Zama Mahlobo, et al.
Research Square|April 29, 2025
Waste to Worth: A diagnostic accuracy of Xpert MTB/XDR on contaminated liquid cultures to salvage the detection of drug-resistant tuberculosisYonas Ghebrekristos, Erick Auma, Zama Mahlobo, et al.
Research Square|March 27, 2026
Bedaquiline and linezolid resistance in people with rifampicin-resistant tuberculosis in the Western Cape Province of South AfricaErick Auma, Yonas Ghebrekristos, Greshan Kisten, et al.
Scientific Reports|November 3, 2017
Mycobacterial genomic DNA from used Xpert MTB/RIF cartridges can be utilised for accurate second-line genotypic drug susceptibility testing and spoligotypingRouxjeane Venter, Brigitta Derendinger, Margaretha de Vos, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
International Journal of Pharmaceutics|February 26, 2008
Comparative diffusion of drugs through bronchial tissueJohann M van Zyl, Brigitta Derendinger, Heiner I Seifart, et al.
Scientific Reports|February 16, 2020
Extract from used Xpert MTB/RIF Ultra cartridges is useful for accurate second-line drug-resistant tuberculosis diagnosis with minimal rpoB-amplicon cross-contamination riskRouxjeane Venter, Stephanie Minnies, Brigitta Derendinger, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 2, 2021
Diagnostic accuracy of the FluoroType MTB and MTBDR VER 2.0 assays for the centralized high-throughput detection of Mycobacterium tuberculosis complex DNA and isoniazid and rifampicin resistanceAnzaan Dippenaar, Brigitta Derendinger, Tania Dolby, et al.
The Journal of Molecular Diagnostics : JMD|February 2, 2022
Frequent Suboptimal Thermocycler Ramp Rate Usage Negatively Impacts GenoType MTBDRsl VER 2.0 Performance for Second-Line Drug-Resistant Tuberculosis DiagnosisBrigitta Derendinger, Margaretha de Vos, Samantha Pillay, et al.
Journal of Clinical Microbiology|July 7, 2018
Diagnostic Accuracy and Utility of FluoroType MTBDR, a New Molecular Assay for Multidrug-Resistant TuberculosisMargaretha de Vos, Brigitta Derendinger, Tania Dolby, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 5, 2022
Non-actionable Results, Accuracy, and Effect of First- and Second-line Line Probe Assays for Diagnosing Drug-Resistant Tuberculosis, Including on Smear-Negative Specimens, in a High-Volume LaboratorySamantha Pillay, Margaretha de Vos, Brigitta Derendinger, et al.
Journal of Clinical Microbiology|July 1, 2025
Waste to worth: diagnostic accuracy of Xpert MTB/XDR on contaminated liquid cultures to salvage the detection of drug-resistant tuberculosisYonas Ghebrekristos, Erick Auma, Zama Mahlobo, et al.
Research Square|April 29, 2025
Waste to Worth: A diagnostic accuracy of Xpert MTB/XDR on contaminated liquid cultures to salvage the detection of drug-resistant tuberculosisYonas Ghebrekristos, Erick Auma, Zama Mahlobo, et al.
Research Square|March 27, 2026
Bedaquiline and linezolid resistance in people with rifampicin-resistant tuberculosis in the Western Cape Province of South AfricaErick Auma, Yonas Ghebrekristos, Greshan Kisten, et al.
Scientific Reports|November 3, 2017
Mycobacterial genomic DNA from used Xpert MTB/RIF cartridges can be utilised for accurate second-line genotypic drug susceptibility testing and spoligotypingRouxjeane Venter, Brigitta Derendinger, Margaretha de Vos, et al.
Pageof 3